Study on molecular mechanism of combined treatment of myocardial infarction with IGF-1 and losartan

YANG Ling-chao,LI Yi-gang,ZHANG Min

DOI: https://doi.org/10.3969/j.issn.1009-0126.2011.06.022

2011-01-01

Abstract:Objective To study the synergistic efficacy and mechanisms of IGF-1 gene transfection and losartan in therapy of acute myocardial infarction in rats.Methods Rat myocardial infarction (MI) models were infected with recombinant adenovirus expressing IGF-1(ADV-IGF-1).Losartan was given by intragastric administration at a dose of 10 mg/(kg·day).One week after MI, angiotensinⅡ(AngⅡ) contents in myocardial tissue were determinated by ELISA assay.The mRNA expression of p53-dependent and regulated genes(p53,AngⅡreceptor) and Bcl-2 was analyzed by real time PCR.The expression of myocardial IGF-1 protein was measured by Western blot.Results The adenovirus-mediated IGF-1 gene transfection was done effectively in rat MI model.Compared with control group and ADV group,in ADV-IGF-1 treated group,gene expression of p53 and AngⅡreceptor was decreased and AngⅡconcentration was also reduced.In losartan treated group,gene expression of IGF-1 was increased.The combination therapy group treated with ADV-IGF-1 and losartan had weak gene expression of p53 and AngⅡreceptor and strong expression of Bcl-2 gene.Conclusion After MI,there were myocardium-specific over-expression of IGF-1 and reduced p53 gene expression,then inhibition of AngⅡreceptor gene expression and production of AngⅡ.Losartan intervention enhanced gene expression of IGF-1. Combination therapy with ADV-IGF-1 and losartan for MI had synergistic effects.